Oramed Pharmaceuticals ORMP
NASDAQ ORMP
$4.69 -0.06 (-1.26%)
At close: Sep 29, 2026 · 4:00 PM EDT

Oramed Pharmaceuticals (ORMP) Share-based Compensation (2010 - 2026)

Updated

Oramed Pharmaceuticals' Share-based Compensation was $1.39 million in Q2 2026, up 74.1% from $800,000 a year earlier but down 19.8% from the prior quarter.

Analysis

Oramed Pharmaceuticals (ORMP) Share-based Compensation (2010 - 2026) Analysis & Trends

On a trailing twelve-month basis, Oramed Pharmaceuticals' Share-based Compensation was $6.13 million through Jun 30, 2026, up 35.7% year-over-year; for FY2025, it was $5.99 million, up 47.8% from FY2024.

  • Share-based Compensation shows a five-year compound annual growth rate of 66.7% (FY2020 to FY2025).
  • In earlier years, Share-based Compensation was $4.05 million in FY2024 (-3.8%), $4.21 million in FY2023 (-63.4%), $11.51 million in FY2022 (+548.0%) and $1.78 million in FY2021.
  • Quarterly Share-based Compensation has moved between $173,000 (Q1 2023) and $4.03 million (Q1 2022) over five years.
  • Compared with a year earlier, Share-based Compensation was higher in four of the last eight quarters, with growth averaging 29.7%.
  • The best year-over-year quarter for Share-based Compensation over five years was Q1 2024 (growth of 648.0%); the worst was Q1 2023 (a decline of 95.7%).
  • Per Business Quant data, ORMP's Share-based Compensation in the three quarters before Q2 2026 was $1.74 million (Q1 2026), $2.28 million (Q4 2025) and $719,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 458.00 Mn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 166.00 Mn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 298.00 Mn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 165.00 Mn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 231.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 249.00 Mn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 170.20 Mn
10 Oramed Pharmaceuticals 196.24 Mn 196.24 Mn - 1.39 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.39 Mn
Mar 31, 2026 1.74 Mn
Dec 31, 2025 2.28 Mn
Sep 30, 2025 719,000.00
Jun 30, 2025 800,000.00
Mar 31, 2025 2.19 Mn
Dec 31, 2024 1.23 Mn
Sep 30, 2024 301,000.00
Jun 30, 2024 1.23 Mn
Mar 31, 2024 1.29 Mn
Dec 31, 2023 1.37 Mn
Sep 30, 2023 852,000.00
Jun 30, 2023 1.82 Mn
Mar 31, 2023 173,000.00
Dec 31, 2022 2.55 Mn
Sep 30, 2022 3.05 Mn
Jun 30, 2022 1.88 Mn
Mar 31, 2022 4.03 Mn
Nov 30, 2021 1.71 Mn
May 31, 2021 982,000.00
API Access

Oramed Pharmaceuticals Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=ORMP&period=max&api_key=YOUR_API_KEY